Analysts await Minerva Neurosciences, Inc (NASDAQ:NERV) to report earnings on Mar, 14 for the fiscal quarter ending Dec 2015.

They expect $-0.36 EPS, up 11.11% or $0.04 from last year’s $-0.4 per share.

At the moment 2 analysts are watching Minerva Neurosciences, Inc (NASDAQ:NERV), 1 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

The biggest institutional shareholders in Minerva Neurosciences, Inc include Federated Investors, Inc. which owns 5 million shares in the company valued at $30.71 million. Index Venture Associates III Ltd is the second biggest holder with 4 million shares currently valued at 22.43 million whilst Fidelity Management and Research Company has 3 million shares valued at 15.32 million.

Total shares held by institutions as of the most recent company filings are 16,940,638 with a reported 3,695,918 bought and 1,207,293 sold. These holdings make up 70.68% of the company’s outstanding shares.

Currently insiders hold 269,981 shares in the business which makes up 1.09% of shares. The biggest holder currently is Mr. Geoff Race who owns 206,648 shares (0.84% of those outstanding), whilst Dr. Rogerio Coelho Vivaldi holds 41,667 (0.17% of shares outstanding) and Frederick W. Ahlholm holds 10,000 (0.04% of shares outstanding).

The stock increased 1.80% or $0.1 during the last trading session.